Your browser doesn't support javascript.
loading
Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments.
Weld, Ethel D; Astemborski, Jacqueline; Kirk, Gregory D; Sulkowski, Mark S; Katz, Stephanie; Rothman, Richard; Solomon, Sunil S; Matthews, Gail V; Hsieh, Yu Hsiang; Verma, Malvika; Traverso, Giovanni; Swindells, Susan; Owen, Andrew; Feld, Jordan; Flexner, Charles; Mehta, Shruti H; Thomas, David L.
Afiliação
  • Weld ED; Department of Medicine, Division of Clinical Pharmacology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Astemborski J; Department of Medicine, Division of Infectious Diseases, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Kirk GD; Department of Medicine, Division of Infectious Diseases, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Sulkowski MS; Department of Medicine, Division of Infectious Diseases, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Katz S; Department of Epidemiology, Division of Infectious Disease Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Rothman R; Department of Medicine, Division of Infectious Diseases, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Solomon SS; Department of Medicine, Division of Infectious Diseases, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Matthews GV; Department of Emergency Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Hsieh YH; Department of Medicine, Division of Infectious Diseases, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Verma M; The University of New South Wales, Sydney, Australia.
  • Traverso G; Department of Emergency Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Swindells S; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Owen A; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Feld J; Division of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Flexner C; Department of Internal Medicine, Section of Infectious Diseases, The University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Mehta SH; Department of Pharmacology and Therapeutics, Centre of Excellence in Long acting Therapeutics (CELT), University of Liverpool, Liverpool, United Kingdomand.
  • Thomas DL; The Toronto Centre for Liver Disease, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Clin Infect Dis ; 75(1): 3-10, 2022 08 24.
Article em En | MEDLINE | ID: mdl-34699587
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C / Hepacivirus Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Child, preschool / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C / Hepacivirus Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Child, preschool / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article